DC9600 |
Senicapoc
|
Senicapoc(ICA17043) is a potent and selective Gardos channel blocker; blocked Ca(2+)-induced rubidium flux from human RBCs/ inhibited RBC dehydration with IC50s of 11 nM/30 nM, respectively.
IC50 value: 11/30 nM [1]
Target: Gardos channel
in vitro: I |
DC8807 |
Retigabine dihydrochloride
|
Retigabine 2Hcl (Ezogabine; D23129) is a Kv7.2-7.5 (KCNQ2-5) neuronal potassium channel opener witrh anticonvulsant activity. |
DC8269 |
NS6180
|
NS6180 is a novel inhibitor of the intermediate-conductance Ca2+-activated K+ channel (KCa3.1) |
DC7833 |
NS309
|
NS309 is a positive modulator of small- and intermediate- conductance Ca2+-activated K+ channels (KCa2 and KCa3.1 channels); increases Ca2+ sensitivity. Displays no activity at BK channels. |
DC6910 |
NS-1643
|
NS1643 is a potent human ether-a-go-go related gene (hERG) KV11.1 channel activator (EC50 = 10.5 μM). |
DC9734 |
NS-1619
|
NS-1619 is a selective MaxiKα (large conductance calcium activated potassium channel) activator. |
DC8789 |
NS 11021
|
NS 11021 is an activator of large-conductance Ca2+-activated potassium channels (BKCa, KCa1.1). |
DC10557 |
ML402
|
ML402 is a selective TREK-1 activator. |
DC7797 |
ML365
|
ML365 is a novel selective small molecule inhibitor of TASK1(KCNK3) with IC50 of 4 nM(thallium influx fluorescent assay) and 16 nM(automated electrophysiology assay). |
DC10743 |
ml335
|
ML335 is a selective activator of both TREK-1 and TREK-2. |